Pancreatic cancer renders a principal cause of cancer mortalities with a dismal prognosis, lacking sufficiently safe and effective therapeutics. Here, we rationally design diversified cyclodiaryliodonium NADPH oxidase (NOX) inhibitors with tens of nanomolar optimal growth inhibition and implement CD44-targeted delivery using synthesized sulfated glycosaminoglycan derivatives. The self-assembled nanoparticle-drug